Filters
Results: 1 to 11 of 11
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Long QT/Brugada Syndrome NGS Panel Fulgent Genetics United States | 69 | 34 |
|
Arrhythmogenic Right Ventricular Cardiomyopathy NGS Panel Fulgent Genetics United States | 118 | 46 |
|
Fulgent Genetics United States | 1 | 1 |
|
Hypertrophic Cardiomyopathy NGS Panel Fulgent Genetics United States | 375 | 86 |
|
Dilated Cardiomyopathy NGS Panel Fulgent Genetics United States | 182 | 78 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Sudden Death Syndrome NGS Panel Fulgent Genetics United States | 168 | 68 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 671 | 250 |
|
Comprehensive Arrhythmia NGS Panel Fulgent Genetics United States | 184 | 76 |
|
Results: 1 to 11 of 11
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.